Comments
Loading...

CytomX Therapeutics Insider Trading Activity

CTMXNASDAQ
Logo brought to you by Benzinga Data

CytomX Therapeutics Insider Trading Activity | NASDAQ:CTMX | Benzinga

Track the latest CytomX Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for CytomX Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are CytomX Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

  • On March 20, 2025, Yu-Waye Chu, the company's CHIEF MEDICAL OFFICER sold 4.03K shares for $0.6 each.
  • On March 20, 2025, Christopher Ogden, the company's CHIEF FINANCIAL OFFICER sold 8.55K shares for $0.6 each.
  • On March 20, 2025, Lloyd Rowland, the company's GENERAL COUNSEL sold 10.2K shares for $0.6 each.

Ownership Statistics for CytomX Therapeutics Inc

Shares Outstanding
157.544M
Insider Shares Owned
2.346M
Insider Percentage Owned
1.49%
Institutional Shares Held
13.802M
Institutional Percentage Held
8.76%
Mar 20, 2025Sean A McCarthyCEO-37.66K$0.60-$22.56KSELL-3.34%1.09MMar 18View
Mar 20, 2025Christopher OgdenCHIEF FINANCIAL OFFICER-8.55K$0.60-$5.12KSELL-4.08%201.03KMar 18View
Mar 20, 2025Yu-Waye ChuCHIEF MEDICAL OFFICER-4.03K$0.60-$2.41KSELL-2.88%135.72KMar 18View
Mar 20, 2025Lloyd RowlandGENERAL COUNSEL-10.20K$0.60-$6.11KSELL-7.80%120.59KMar 18View
Mar 20, 2025Marcia BelvinSVP, CHIEF SCIENTIFIC OFFICER-19.51K$0.60-$11.69KSELL-7.28%248.64KMar 18View
Aug 22, 2024Jeffrey B LandauCHIEF BUSINESS OFFICER7.07K$1.23-$5.14KSELL-OPTIONS6.14%122.24KAug 20View
Aug 22, 2024Marcia BelvinSVP, CHIEF SCIENTIFIC OFFICER7.07K$1.23-$5.14KSELL-OPTIONS4.19%175.65KAug 20View
Aug 22, 2024Lloyd RowlandGENERAL COUNSEL7.07K$1.23-$5.14KSELL-OPTIONS5.71%130.80KAug 20View
Aug 22, 2024Christopher OgdenCHIEF FINANCIAL OFFICER4.89K$1.23-$2.44KSELL-OPTIONS4.74%108.08KAug 20View
Aug 22, 2024Sean A McCarthyCEO23.60K$1.23-$17.08KSELL-OPTIONS3.24%751.01KAug 20View
Mar 21, 2024Lloyd RowlandGENERAL COUNSEL-5.27K$2.09-$10.99KSELL-4.28%117.73KMar 19View
Mar 21, 2024Sean A McCarthyCEO-20.22K$2.09-$42.18KSELL-3.17%617.64KMar 19View
Mar 21, 2024Christopher OgdenSVP, FINANCE AND ACCOUNTING-2.97K$2.09-$6.20KSELL-3.35%85.69KMar 19View
Mar 21, 2024Marcia BelvinSVP, CHIEF SCIENTIFIC OFFICER-12.79K$2.09-$26.68KSELL-7.05%168.58KMar 19View
Mar 21, 2024Jeffrey B LandauCHIEF BUSINESS OFFICER-6.56K$2.09-$13.69KSELL-5.48%113.24KMar 19View
Dec 22, 2023Sean A McCarthyCEO-13.55K$1.38-$18.71KSELL-2.41%547.86KDec 20View
Dec 22, 2023Marcia BelvinSVP, CHIEF SCIENTIFIC OFFICER-4.08K$1.38-$5.63KSELL-2.56%155.12KDec 20View
Dec 22, 2023Jeffrey B LandauCHIEF BUSINESS OFFICER-4.08K$1.38-$5.63KSELL-4.34%89.80KDec 20View
Dec 22, 2023Lloyd RowlandGENERAL COUNSEL-4.08K$1.38-$5.63KSELL-3.99%98.00KDec 20View
Dec 22, 2023Christopher OgdenSVP, FINANCE AND ACCOUNTING-1.99K$1.38-$2.75KSELL-3.93%48.66KDec 20View
Sep 22, 2023Marcia BelvinSVP, CHIEF SCIENTIFIC OFFICER7.13K$1.30-$5.36KGRANT5.06%147.95KSep 20 - Sep 22View
Sep 22, 2023Jeffrey B LandauCHIEF BUSINESS OFFICER7.13K$1.30-$5.36KGRANT9.85%79.56KSep 20 - Sep 22View
Sep 22, 2023Sean A McCarthyCEO25.40K$1.30-$18.99KGRANT5.09%523.91KSep 20 - Sep 22View
Sep 22, 2023Lloyd RowlandGENERAL COUNSEL9.51K$1.30-$7.14KGRANT13.38%80.61KSep 20 - Sep 22View
Mar 31, 2023Elaine V Jones—5.00K$1.55$7.75KBUY3521.13%5.14KMar 29View
Mar 20, 2023Christopher OgdenSVP, FINANCE AND ACCOUNTING-516.00$1.98-$1.02KSELL-1.35%37.77KMar 16View
Mar 20, 2023Carlos CampoyCHIEF FINANCIAL OFFICER-1.75K$1.98-$3.46KSELL-4.37%38.22KMar 16View
Mar 20, 2023Sean A McCarthyCEO-7.12K$1.88-$13.39KSELL-1.46%481.98KMar 16View
Mar 20, 2023Lloyd RowlandGENERAL COUNSEL-2.04K$1.98-$4.03KSELL-2.79%71.09KMar 16View
Mar 20, 2023Jeffrey B LandauCHIEF FINANCIAL OFFICER-1.48K$1.98-$2.92KSELL-2.00%72.43KMar 16View
Mar 20, 2023Amy C PetersonEVP, CHIEF DEVELOPMENT OFFICER-4.26K$1.98-$8.42KSELL-6.79%58.43KMar 16View
Jul 21, 2022Amy C PetersonEVP, CHIEF DEVELOPMENT OFFICER12.54K$1.42-$10.61KGRANT25.00%62.69KJul 19 - Jul 20View
Jul 21, 2022Jeffrey B LandauCHIEF BUSINESS OFFICER7.04K$1.42-$5.98KGRANT26.22%33.91KJul 19 - Jul 20View
Jul 21, 2022Sean A McCarthyPRESIDENT AND CEO25.09K$1.42-$21.21KGRANT6.99%384.10KJul 19 - Jul 20View
Jul 21, 2022Lloyd RowlandGENERAL COUNSEL9.40K$1.42-$7.97KGRANT27.41%43.69KJul 19 - Jul 20View
Jul 21, 2022Alison L HannahCHIEF MEDICAL OFFICER9.40K$1.42-$7.97KGRANT41.77%31.90KJul 19 - Jul 20View
Jul 21, 2022Carlos CampoyCHIEF FINANCIAL OFFICER11.05K$1.42-$5.62KGRANT38.21%39.97KJul 19 - Jul 20View
Jun 21, 2021Sean A McCarthyPRESIDENT AND CEO-100.00K$7.04-$704.47KSELL-49.76%100.97KJun 16View
Apr 02, 2021Sean A McCarthyPRESIDENT AND CEO0.00$4.31-$636.08KSELL-OPTIONS0.00%206.89KMar 31View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch